
The system is designed to deliver photon augmented wave stereotactic radiation therapy

The system is designed to deliver photon augmented wave stereotactic radiation therapy

A concise Q&A for veterinarians summarizing identification, reporting, treatment, prevention, and practical next steps as New World screwworm approaches the US border.

Jack Teitelman, CEO and founder of TITAN Group, shares key takeaways from his New York Vet Show session on DEA compliance.

dvm360’s Australian correspondent Phil Tucak also provides updates on the suicide prevention initiative VetHerd and veterinary AI scribe Sidekick.

Upcoming industry events for earning continuing education credits.

Lindsay Hallman, CVT, CCMT, VTS (Oncology), and Katelyn McDonald, CVT, VTS (Oncology), discuss clinical administration of oncology therapy, in a dvm360 interview.

This Thanksgiving, veterinary professionals celebrate the community's dedication, expressing gratitude for each other, mentorship, the human-animal bond, and more.

Dion Small, BSc, LVT, found his passion for animal care and a purpose in leadership

In celebration of the holiday, dvm360® has spotlighted 3 relevant articles to feast on.

The single-injection monoclonal antibody (Lenivia) from Zoetis reduces OA pain in dogs for 3 months.

blendVET founder Niccole Bruno, DVM, explains how hands-on veterinary programming, distributed mentorship, and hybrid clinic-school partnerships can diversify the veterinary pipeline and expand access to care

Investigators with the Dog Aging Project assessed 1726 feeding plans created by pet owners.

Megan Shepherd, DVM, PhD, DACVIM (Nutrition), shares how yeast-based probiotics offer unique advantages over traditional bacteria-based options.

Whether the push is for diagnostics, optimal treatments, or solid preventive measures, leading owners to sound decisions for their pets’ health might be the veterinarian’s toughest task.

A practical guide to evidence-based, integrative pain management that combines drugs and nonpharmacologic modalities to improve outcomes, reduce caregiver burden, and keep animals moving.

Lindsay Hallman, CVT, CCMT, VTS (Oncology), and Katelyn McDonald, CVT, VTS (Oncology), discuss what oncology patients may experience in a dvm360 interview.

Cornell University is enrolling client-owned cats in an 11-week trial of AKS-562c, a once-weekly GLP-1 Fc-fusion candidate designed to reduce appetite and produce clinically meaningful weight loss while closely monitoring safety and tolerability.

Veterinarians share holiday pet emergencies, highlighting risks from decorations and toxic foods, while offering tips to keep pets safe this season.

Here is a sneak peek at this week’s headlines.

New leadership moves, recognition, and achievement.

The new school at Clemson University aims to welcome its first students in fall 2026.

The top cause is periodontal disease, explains Heidi Lobprise, DVM, DAVDC.

The highly contagious virus has been linked to a recent rodeo event, with known cases diagnosed in horses from Texas and Oklahoma.

Penn Vet Working Dog Center trials show that a trained, 30-second, voluntary head dunk can rapidly lower core temperature in cooperative dogs.

The FDA determined that Credelio Cat may be effective in treating New World screwworm infestations in cats and kittens.

The Drug Enforcement Administration is auditing veterinary clinics more frequently than before, explains Jack Teitelman, CEO of a DEA regulatory consulting firm, in this Q&A.

Check out this week’s headlines.

Boehringer Ingelheim earned positive opinions for 2 immunization therapies in the pipeline.

The initiative comes as wildfires and other disasters pose an increasing risk to pets in Canada.

OS Therapeutics' veterinary division is developing OST-HER2 for canine osteosarcoma treatment.